Concepedia

Lydie Lefrançois

LL

13

Publications

989

Citations

13

H-Index

2000

Active since

Affiliations

Inserm(Current)

Centre de Recherche en Cancérologie de Lyon

Université Claude Bernard Lyon 1

Purdue University West Lafayette

Centre National de la Recherche Scientifique

Lydie Lefrançois is an author at Inserm specializing in medicine, hepatocellular carcinoma, and pathology.

Top concepts

Publications per year

2000–2019

13

Publications

13

Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma

A. Bengochéa, M.M. De Souza, Lydie Lefrançois et al. · British Journal of Cancer · 2008 · 207 citations · Full text

Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo

Luc Barraud, Philippe Merle, Emilienne Soma et al. · Journal of Hepatology · 2005 · 206 citations

, , +10

Oncogenic role of the frizzled-7/β-catenin pathway in hepatocellular carcinoma

Philippe Merle, Miran Kim, Marc Herrmann et al. · Journal of Hepatology · 2005 · 159 citations

, , +3

Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma

Sarah B. Nambotin, Lydie Lefrançois, Xavier Sainsily et al. · Journal of Hepatology · 2010 · 87 citations

, , +9

EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes

Saravana Kumar Kailasam Mani, Hao Zhang, Ahmed Diab et al. · Journal of Hepatology · 2016 · 59 citations · Full text

, , +11

Rows per page

1–5 of 13